betamethasone + calcipotriol


LEO Pharma


Concise Prescribing Info
Per g Calcipotriol hydrate 50 mcg, betamethasone dipropionate 0.5 mg
Initial topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy.
Dosage/Direction for Use
Apply once daily to affected area. Recommended treatment period: 4 wk. Max: Not to exceed 15 g daily. Max treated area: Not to exceed 30% BSA.
Hypersensitivity. Ca metabolism disorders, viral, fungal or bacterial skin infections, parasitic infections, skin TB manifestations, rosacea, perioral dermatitis, acne vulgaris, skin atrophy, striae atrophicae, fragility of skin veins, ichthyosis, acne rosacea, ulcers & wounds; erythrodermic, exfoliative & pustular psoriasis.
Special Precautions
Discontinue use if infection worsens or hypercalcaemia occurs. Risk of generalised pustular psoriasis or rebound effects upon discontinuation; guttate psoriasis. Avoid application under occlusive dressings, on large areas of damaged skin, on mucous membranes or in skin folds. Avoid contact w/ face, mouth & eyes. Limit or avoid excessive exposure to either natural or artificial sunlight. Avoid concurrent treatment w/ other steroids. Long-term use. Severe renal insufficiency or hepatic disorders. Pregnancy & lactation.
Adverse Reactions
ATC Classification
D05AX52 - calcipotriol, combinations ; Belongs to the class of other antipsoriatics for topical use.
Daivobet oint
30 g x 1's (RM134.3/tube)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in